P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Moreau, Philippe, van de Donk, Niels W.C.J., Delforge, Michel, Einsele, Hermann, De Stefano, Valerio, Perrot, Aurore, Besemer, Britta, Pawlyn, Charlotte, Karlin, Lionel, Manier, Salomon, Leleu, Xavier, Thilakarathne, Pushpike, Diels, Joris, Gries, Katharine, Erler-Yates, Nichola, van Nimwegen, Kirsten, Morano, Raúl, Strulev, Vadim, Haddad, Imene, Kobos, Rachel, Smit, Jennifer, Marshall, Alexander, Slavcev, Mary, Mateos, Maria-Victoria, Weisel, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431245/
http://dx.doi.org/10.1097/01.HS9.0000970820.69075.8f
_version_ 1785091155680034816
author Moreau, Philippe
van de Donk, Niels W.C.J.
Delforge, Michel
Einsele, Hermann
De Stefano, Valerio
Perrot, Aurore
Besemer, Britta
Pawlyn, Charlotte
Karlin, Lionel
Manier, Salomon
Leleu, Xavier
Thilakarathne, Pushpike
Diels, Joris
Gries, Katharine
Erler-Yates, Nichola
van Nimwegen, Kirsten
Morano, Raúl
Strulev, Vadim
Haddad, Imene
Kobos, Rachel
Smit, Jennifer
Marshall, Alexander
Slavcev, Mary
Mateos, Maria-Victoria
Weisel, Katja
author_facet Moreau, Philippe
van de Donk, Niels W.C.J.
Delforge, Michel
Einsele, Hermann
De Stefano, Valerio
Perrot, Aurore
Besemer, Britta
Pawlyn, Charlotte
Karlin, Lionel
Manier, Salomon
Leleu, Xavier
Thilakarathne, Pushpike
Diels, Joris
Gries, Katharine
Erler-Yates, Nichola
van Nimwegen, Kirsten
Morano, Raúl
Strulev, Vadim
Haddad, Imene
Kobos, Rachel
Smit, Jennifer
Marshall, Alexander
Slavcev, Mary
Mateos, Maria-Victoria
Weisel, Katja
author_sort Moreau, Philippe
collection PubMed
description
format Online
Article
Text
id pubmed-10431245
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104312452023-08-17 P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA Moreau, Philippe van de Donk, Niels W.C.J. Delforge, Michel Einsele, Hermann De Stefano, Valerio Perrot, Aurore Besemer, Britta Pawlyn, Charlotte Karlin, Lionel Manier, Salomon Leleu, Xavier Thilakarathne, Pushpike Diels, Joris Gries, Katharine Erler-Yates, Nichola van Nimwegen, Kirsten Morano, Raúl Strulev, Vadim Haddad, Imene Kobos, Rachel Smit, Jennifer Marshall, Alexander Slavcev, Mary Mateos, Maria-Victoria Weisel, Katja Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431245/ http://dx.doi.org/10.1097/01.HS9.0000970820.69075.8f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Moreau, Philippe
van de Donk, Niels W.C.J.
Delforge, Michel
Einsele, Hermann
De Stefano, Valerio
Perrot, Aurore
Besemer, Britta
Pawlyn, Charlotte
Karlin, Lionel
Manier, Salomon
Leleu, Xavier
Thilakarathne, Pushpike
Diels, Joris
Gries, Katharine
Erler-Yates, Nichola
van Nimwegen, Kirsten
Morano, Raúl
Strulev, Vadim
Haddad, Imene
Kobos, Rachel
Smit, Jennifer
Marshall, Alexander
Slavcev, Mary
Mateos, Maria-Victoria
Weisel, Katja
P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
title P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_fullStr P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full_unstemmed P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_short P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_sort p979: patient-reported outcomes for teclistamab versus real-world physician’s choice of therapy in the locommotion study in patients with triple-class exposed relapsed/refractory multiple myeloma
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431245/
http://dx.doi.org/10.1097/01.HS9.0000970820.69075.8f
work_keys_str_mv AT moreauphilippe p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT vandedonknielswcj p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT delforgemichel p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT einselehermann p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT destefanovalerio p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT perrotaurore p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT besemerbritta p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT pawlyncharlotte p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT karlinlionel p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT maniersalomon p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT leleuxavier p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT thilakarathnepushpike p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT dielsjoris p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT grieskatharine p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT erleryatesnichola p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT vannimwegenkirsten p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT moranoraul p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT strulevvadim p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT haddadimene p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT kobosrachel p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT smitjennifer p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT marshallalexander p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT slavcevmary p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT mateosmariavictoria p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma
AT weiselkatja p979patientreportedoutcomesforteclistamabversusrealworldphysicianschoiceoftherapyinthelocommotionstudyinpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma

Ejemplares similares